| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = -$1 ) |
| | 2025 | 2021 | NEW YORK UNIVERSITY | 101 MINEOLA BLVD | MINEOLA | NY | 11501-4089 | NASSAU | USA | R01HL141733 | Roles of Nogo-B receptor in maintaining the structural integrity of blood vessels | 000 | 4 | NIH | 11/23/2024 | -$1 |
|
| Issue Date FY: 2024 ( Subtotal = $6,335,436 ) |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 101 MINEOLA BLVD | MINEOLA | NY | 11501-4089 | NASSAU | USA | R01HD098258 | Placenta-specific miR-519c-mediated induction of immune tolerance in human placenta | 002 | 6 | NIH | 5/23/2024 | $29,203 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 101 MINEOLA BLVD | MINEOLA | NY | 11501-4089 | NASSAU | USA | R01HL169313 | Bmal1, a master regulator of Macrophage cholesterol metabolism | 001 | 1 | NIH | 5/31/2024 | $56,848 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 101 MINEOLA BLVD | MINEOLA | NY | 11501-4089 | NASSAU | USA | P01HL160470 | Analytical Integration of Lipoprotein Lipidomics | 000 | 2 | NIH | 4/1/2024 | $2,221,131 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 101 MINEOLA BLVD | MINEOLA | NY | 11501-4089 | NASSAU | USA | U18DP006633 | DP20-001 Assessing the Burden of Diabetes By Type in Children, Adolescents and Young Adults (DiCAYA) - 2020 | 00 | 5 | CDC | 6/7/2024 | $54,005 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 101 MINEOLA BLVD | MINEOLA | NY | 11501-4089 | NASSAU | USA | R01HL158054 | Mapping MTP lipid transfer activities for better therapeutics | 000 | 4 | NIH | 3/11/2024 | $549,522 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 101 MINEOLA BLVD | MINEOLA | NY | 11501-4089 | NASSAU | USA | P01HL160470 | Analytical Integration of Lipoprotein Lipidomics | 001 | 2 | NIH | 6/13/2024 | $197,435 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 101 MINEOLA BLVD | MINEOLA | NY | 11501-4089 | NASSAU | USA | P01HL160470 | Analytical Integration of Lipoprotein Lipidomics | 002 | 2 | NIH | 8/29/2024 | $0 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 101 MINEOLA BLVD | MINEOLA | NY | 11501-4089 | NASSAU | USA | R01HL158054 | Mapping MTP lipid transfer activities for better therapeutics | 001 | 4 | NIH | 6/20/2024 | $48,847 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 101 MINEOLA BLVD | MINEOLA | NY | 11501-4089 | NASSAU | USA | R01DK132056 | Role of NgBR in regulating hepatic gluconeogenesis and insulin resistance | 000 | 3 | NIH | 3/20/2024 | $539,004 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 101 MINEOLA BLVD | MINEOLA | NY | 11501-4089 | NASSAU | USA | U18DP006633 | DP20-001 Assessing the Burden of Diabetes By Type in Children, Adolescents and Young Adults (DiCAYA) - 2020 | 00 | 5 | CDC | 6/7/2024 | $445,995 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 101 MINEOLA BLVD | MINEOLA | NY | 11501-4089 | NASSAU | USA | R01HD098258 | Placenta-specific miR-519c-mediated induction of immune tolerance in human placenta | 003 | 6 | NIH | 8/28/2024 | $91,245 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 101 MINEOLA BLVD | MINEOLA | NY | 11501-4089 | NASSAU | USA | R01HL166214 | Regulation of plasma LDL and HDL by microRNA-541-3p | 000 | 2 | NIH | 6/27/2024 | $619,239 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 101 MINEOLA BLVD | MINEOLA | NY | 11501-4089 | NASSAU | USA | R01HL166214 | Regulation of plasma LDL and HDL by microRNA-541-3p | 001 | 2 | NIH | 8/15/2024 | $0 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 101 MINEOLA BLVD | MINEOLA | NY | 11501-4089 | NASSAU | USA | R01DK135630 | Role of Retinoid X Receptor Alpha in regulating PCSK9 transcription in the liver | 001 | 2 | NIH | 5/15/2024 | $37,489 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 101 MINEOLA BLVD | MINEOLA | NY | 11501-4089 | NASSAU | USA | R01DK135630 | Role of Retinoid X Receptor Alpha in regulating PCSK9 transcription in the liver | 000 | 2 | NIH | 2/16/2024 | $562,346 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 101 MINEOLA BLVD | MINEOLA | NY | 11501-4089 | NASSAU | USA | R01DK132056 | Role of NgBR in regulating hepatic gluconeogenesis and insulin resistance | 001 | 3 | NIH | 5/22/2024 | $35,933 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 101 MINEOLA BLVD | MINEOLA | NY | 11501-4089 | NASSAU | USA | P01HL160470 | Analytical Integration of Lipoprotein Lipidomics | 003 | 2 | NIH | 9/17/2024 | $46,785 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 101 MINEOLA BLVD | MINEOLA | NY | 11501-4089 | NASSAU | USA | R01HL169313 | Bmal1, a master regulator of Macrophage cholesterol metabolism | 000 | 1 | NIH | 3/8/2024 | $511,631 |
| | 2024 | 2024 | NEW YORK UNIVERSITY | 101 MINEOLA BLVD | MINEOLA | NY | 11501-4089 | NASSAU | USA | R01HD098258 | Placenta-specific miR-519c-mediated induction of immune tolerance in human placenta | 001 | 6 | NIH | 4/11/2024 | $292,030 |
| | 2024 | 2023 | NEW YORK UNIVERSITY | 101 MINEOLA BLVD | MINEOLA | NY | 11501-4089 | NASSAU | USA | R01HD098258 | Placenta-specific miR-519c-mediated induction of immune tolerance in human placenta | 000 | 5 | NIH | 11/17/2023 | $0 |
| | 2024 | 2023 | NEW YORK UNIVERSITY | 101 MINEOLA BLVD | MINEOLA | NY | 11501-4089 | NASSAU | USA | U18DP006633 | DP20-001 Assessing the Burden of Diabetes By Type in Children, Adolescents and Young Adults (DiCAYA) - 2020 | 00 | 5 | CDC | 6/7/2024 | $0 |
| | 2024 | 2023 | NEW YORK UNIVERSITY | 101 MINEOLA BLVD | MINEOLA | NY | 11501-4089 | NASSAU | USA | U18DP006633 | DP20-001 Assessing the Burden of Diabetes By Type in Children, Adolescents and Young Adults (DiCAYA) - 2020 | 00 | 5 | CDC | 6/7/2024 | $0 |
| | 2024 | 2022 | NEW YORK UNIVERSITY | 101 MINEOLA BLVD | MINEOLA | NY | 11501-4089 | NASSAU | USA | U18DP006633 | DP20-001 Assessing the Burden of Diabetes By Type in Children, Adolescents and Young Adults (DiCAYA) - 2020 | 00 | 5 | CDC | 6/7/2024 | $0 |
| | 2024 | 2022 | NEW YORK UNIVERSITY | 101 MINEOLA BLVD | MINEOLA | NY | 11501-4089 | NASSAU | USA | R01MD013886 | The long-term effectiveness of and the disparities in access to treatments for obstructive sleep apnea: a study on the All of Us data | 001 | 5 | NIH | 2/7/2024 | $0 |
| | 2024 | 2022 | NEW YORK UNIVERSITY | 101 MINEOLA BLVD | MINEOLA | NY | 11501-4089 | NASSAU | USA | R01MD013886 | The long-term effectiveness of and the disparities in access to treatments for obstructive sleep apnea: a study on the All of Us data | 000 | 5 | NIH | 2/7/2024 | $0 |
| | 2024 | 2022 | NEW YORK UNIVERSITY | 101 MINEOLA BLVD | MINEOLA | NY | 11501-4089 | NASSAU | USA | U18DP006633 | DP20-001 Assessing the Burden of Diabetes By Type in Children, Adolescents and Young Adults (DiCAYA) - 2020 | 00 | 5 | CDC | 6/7/2024 | $0 |
| | 2024 | 2022 | NEW YORK UNIVERSITY | 101 MINEOLA BLVD | MINEOLA | NY | 11501-4089 | NASSAU | USA | R01MD013886 | The long-term effectiveness of and the disparities in access to treatments for obstructive sleep apnea: a study on the All of Us data | 002 | 5 | NIH | 2/7/2024 | $0 |
| | 2024 | 2021 | NEW YORK UNIVERSITY | 101 MINEOLA BLVD | MINEOLA | NY | 11501-4089 | NASSAU | USA | R21HD100653 | Cold milk as a novel therapy for dysphagia in preterm infants | 000 | 2 | NIH | 2/14/2024 | $0 |
| | 2024 | 2021 | NEW YORK UNIVERSITY | 101 MINEOLA BLVD | MINEOLA | NY | 11501-4089 | NASSAU | USA | R01DK121490 | Circadian Regulation of Lipoprotein Assembly | 000 | 3 | NIH | 2/8/2024 | $0 |
| | 2024 | 2021 | NEW YORK UNIVERSITY | 101 MINEOLA BLVD | MINEOLA | NY | 11501-4089 | NASSAU | USA | R01DK112971 | Role of NgBR in Hepatic Steatosis | 000 | 6 | NIH | 11/20/2023 | -$2,920 |
| | 2024 | 2020 | NEW YORK UNIVERSITY | 101 MINEOLA BLVD | MINEOLA | NY | 11501-4089 | NASSAU | USA | R01HL137202 | Effects of miR-30c deficiency on plasma cholesterol and atherosclerosis | 000 | 5 | NIH | 12/19/2023 | -$333 |
|
| Issue Date FY: 2023 ( Subtotal = $5,829,008 ) (Continued on the next page) |
| | 2023 | 2023 | NEW YORK UNIVERSITY | 101 MINEOLA BLVD | MINEOLA | NY | 11501-4089 | NASSAU | USA | P01HL160470 | Analytical Integration of Lipoprotein Lipidomics | 000 | 1 | NIH | 4/28/2023 | $2,485,299 |
| | 2023 | 2023 | NEW YORK UNIVERSITY | 101 MINEOLA BLVD | MINEOLA | NY | 11501-4089 | NASSAU | USA | R01HD098258 | Placenta-specific miR-519c-mediated induction of immune tolerance in human placenta | 000 | 5 | NIH | 2/23/2023 | $324,478 |
| | 2023 | 2023 | NEW YORK UNIVERSITY | 101 MINEOLA BLVD | MINEOLA | NY | 11501-4089 | NASSAU | USA | R01HD098258 | Placenta-specific miR-519c-mediated induction of immune tolerance in human placenta | 001 | 5 | NIH | 8/30/2023 | $54,347 |
| | 2023 | 2023 | NEW YORK UNIVERSITY | 101 MINEOLA BLVD | MINEOLA | NY | 11501-4089 | NASSAU | USA | U18DP006633 | DP20-001 Assessing the Burden of Diabetes By Type in Children, Adolescents and Young Adults (DiCAYA) - 2020 | 00 | 4 | CDC | 5/31/2023 | $445,995 |
| | 2023 | 2023 | NEW YORK UNIVERSITY | 101 MINEOLA BLVD | MINEOLA | NY | 11501-4089 | NASSAU | USA | U18DP006633 | DP20-001 Assessing the Burden of Diabetes By Type in Children, Adolescents and Young Adults (DiCAYA) - 2020 | 00 | 4 | CDC | 5/31/2023 | $54,005 |
| | 2023 | 2023 | NEW YORK UNIVERSITY | 101 MINEOLA BLVD | MINEOLA | NY | 11501-4089 | NASSAU | USA | R01HL158054 | Mapping MTP lipid transfer activities for better therapeutics | 000 | 3 | NIH | 3/8/2023 | $610,581 |
| | 2023 | 2023 | NEW YORK UNIVERSITY | 101 MINEOLA BLVD | MINEOLA | NY | 11501-4089 | NASSAU | USA | R01DK132056 | Role of NgBR in regulating hepatic gluconeogenesis and insulin resistance | 002 | 2 | NIH | 4/11/2023 | $592,536 |
| | 2023 | 2023 | NEW YORK UNIVERSITY | 101 MINEOLA BLVD | MINEOLA | NY | 11501-4089 | NASSAU | USA | R01DK135630 | Role of Retinoid X Receptor Alpha in regulating PCSK9 transcription in the liver | 000 | 1 | NIH | 3/2/2023 | $609,306 |
| | 2023 | 2023 | NEW YORK UNIVERSITY | 101 MINEOLA BLVD | MINEOLA | NY | 11501-4089 | NASSAU | USA | R01DK135630 | Role of Retinoid X Receptor Alpha in regulating PCSK9 transcription in the liver | 001 | 1 | NIH | 3/20/2023 | -$609,306 |
| | 2023 | 2023 | NEW YORK UNIVERSITY | 101 MINEOLA BLVD | MINEOLA | NY | 11501-4089 | NASSAU | USA | R01DK135630 | Role of Retinoid X Receptor Alpha in regulating PCSK9 transcription in the liver | 002 | 1 | NIH | 3/23/2023 | $629,891 |
| | 2023 | 2023 | NEW YORK UNIVERSITY | 101 MINEOLA BLVD | MINEOLA | NY | 11501-4089 | NASSAU | USA | R01HL166214 | Regulation of plasma LDL and HDL by microRNA-541-3p | 000 | 1 | NIH | 6/1/2023 | $631,876 |
| | 2023 | 2022 | NEW YORK UNIVERSITY | 101 MINEOLA BLVD | MINEOLA | NY | 11501-4089 | NASSAU | USA | U18DP006633 | DP20-001 Assessing the Burden of Diabetes By Type in Children, Adolescents and Young Adults (DiCAYA) - 2020 | 00 | 4 | CDC | 5/31/2023 | $0 |
| | 2023 | 2022 | NEW YORK UNIVERSITY | 101 MINEOLA BLVD | MINEOLA | NY | 11501-4089 | NASSAU | USA | U18DP006633 | DP20-001 Assessing the Burden of Diabetes By Type in Children, Adolescents and Young Adults (DiCAYA) - 2020 | 00 | 4 | CDC | 5/31/2023 | $0 |
| | 2023 | 2022 | NEW YORK UNIVERSITY | 101 MINEOLA BLVD | MINEOLA | NY | 11501-4089 | NASSAU | USA | R01DK132056 | Role of NgBR in regulating hepatic gluconeogenesis and insulin resistance | 000 | 1 | NIH | 2/28/2023 | -$585,581 |
| | 2023 | 2022 | NEW YORK UNIVERSITY | 101 MINEOLA BLVD | MINEOLA | NY | 11501-4089 | NASSAU | USA | R01DK132056 | Role of NgBR in regulating hepatic gluconeogenesis and insulin resistance | 001 | 1 | NIH | 3/3/2023 | $585,581 |
|
